Payment overview · 2025
General Payments
$137.26
1 reported records · 1 companies
Healthcare provider profile · identity verified
Kate Szymanski, DO
Allopathic & Osteopathic Physicians|Family Medicine · ANN ARBOR, MI · NPI 1871954206
Verified facts
What the public records show
CMS Open Payments records show Kate Szymanski, DO received $137.26 in general payments during 2025 across 1 reported records.
Boston Scientific Corporation accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Boston Scientific Corporation | Unresolved — no canonical attribution shown | $137.26 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $137.26 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| WATCHMAN FLX Normalized: watchman flx |
Device | Boston Scientific Corporation | $137.26 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
None of this doctor’s payer companies has same-entity product evidence that passes the publication threshold. The site does not infer company ownership, affiliates, or generic manufacturers.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 535 | 105 |
| Potassium Chloride | Potassium Chloride | 350 | 44 |
| Sertraline Hcl | Sertraline Hcl | 339 | 47 |
| Levothyroxine Sodium | Levothyroxine Sodium | 303 | 61 |
| Eliquis | Apixaban | 296 | 32 |
| Gabapentin | Gabapentin | 291 | 52 |
| Lisinopril | Lisinopril | 281 | 53 |
| Pantoprazole Sodium | Pantoprazole Sodium | 268 | 46 |
| Furosemide | Furosemide | 255 | 48 |
| Amlodipine Besylate | Amlodipine Besylate | 209 | 49 |
| Losartan Potassium | Losartan Potassium | 188 | 41 |
| Metformin Hcl | Metformin Hcl | 179 | 37 |
| Metoprolol Tartrate | Metoprolol Tartrate | 166 | 31 |
| Tamsulosin Hcl | Tamsulosin Hcl | 166 | 31 |
| Metoprolol Succinate | Metoprolol Succinate | 158 | 41 |
| Mirtazapine | Mirtazapine | 156 | 28 |
| Trazodone Hcl | Trazodone Hcl | 147 | 25 |
| Bumetanide | Bumetanide | 144 | 26 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 143 | 27 |
| Buspirone Hcl | Buspirone Hcl | 131 | 21 |
| Farxiga | Dapagliflozin Propanediol | 127 | 20 |
| Famotidine | Famotidine | 120 | 30 |
| Omeprazole | Omeprazole | 119 | 34 |
| Carvedilol | Carvedilol | 111 | 31 |
| Alendronate Sodium | Alendronate Sodium | 108 | 25 |
| Fluticasone Propionate | Fluticasone Propionate | 103 | 45 |
| Donepezil Hcl | Donepezil Hcl | 96 | 15 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 95 | 48 |
| Hydrochlorothiazide | Hydrochlorothiazide | 95 | 23 |
| Midodrine Hcl | Midodrine Hcl | 92 | 18 |
| Cephalexin | Cephalexin | 88 | 24 |
| Jardiance | Empagliflozin | 88 | 15 |
| Montelukast Sodium | Montelukast Sodium | 87 | 20 |
| Clopidogrel | Clopidogrel Bisulfate | 82 | 15 |
| Ezetimibe | Ezetimibe | 80 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 79 | 22 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 78 | suppressed |
| Pregabalin | Pregabalin | 78 | suppressed |
| Escitalopram Oxalate | Escitalopram Oxalate | 77 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 75 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 75 | suppressed |
| Risperidone | Risperidone | 73 | suppressed |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 73 | 17 |
| Spironolactone | Spironolactone | 73 | 14 |
| Ozempic | Semaglutide | 72 | 15 |
| Quetiapine Fumarate | Quetiapine Fumarate | 68 | suppressed |
| Allopurinol | Allopurinol | 66 | 11 |
| Januvia | Sitagliptin Phosphate | 66 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 62 | suppressed |
| Levetiracetam | Levetiracetam | 59 | suppressed |
| Lactulose | Lactulose | 58 | 12 |
| Metoclopramide Hcl | Metoclopramide Hcl | 58 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 58 | 17 |
| Citalopram Hbr | Citalopram Hydrobromide | 57 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 57 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 56 | suppressed |
| Baclofen | Baclofen | 51 | suppressed |
| Xarelto | Rivaroxaban | 50 | suppressed |
| Primidone | Primidone | 49 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 49 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 48 | 14 |
| Duloxetine Hcl | Duloxetine Hcl | 48 | 15 |
| Myrbetriq | Mirabegron | 48 | suppressed |
| Trulicity | Dulaglutide | 48 | 15 |
| Prednisone | Prednisone | 47 | 18 |
| Incruse Ellipta | Umeclidinium Bromide | 46 | 12 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 46 | suppressed |
| Meloxicam | Meloxicam | 46 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 45 | 15 |
| Simvastatin | Simvastatin | 43 | suppressed |
| Bupropion Xl | Bupropion Hcl | 42 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 42 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 42 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 40 | suppressed |
| Tradjenta | Linagliptin | 40 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 39 | suppressed |
| Ibuprofen | Ibuprofen | 39 | 11 |
| Divalproex Sodium Er | Divalproex Sodium | 37 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 36 | suppressed |
| Nifedipine Er | Nifedipine | 36 | suppressed |
| Topiramate | Topiramate | 36 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 35 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 35 | 18 |
| Celecoxib | Celecoxib | 33 | suppressed |
| Atenolol | Atenolol | 31 | suppressed |
| Entresto | Sacubitril/Valsartan | 31 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 30 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 30 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 29 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 28 | suppressed |
| Novolog Flexpen | Insulin Aspart | 26 | 11 |
| Amiodarone Hcl | Amiodarone Hcl | 25 | suppressed |
| Carbamazepine | Carbamazepine | 25 | suppressed |
| Lorazepam | Lorazepam | 25 | suppressed |
| Rivastigmine | Rivastigmine Tartrate | 24 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 23 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 23 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 23 | suppressed |
| Humulin R U-500 Kwikpen | Insulin Regular, Human | 22 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 22 | suppressed |
| Lamotrigine | Lamotrigine | 22 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 21 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 21 | suppressed |
| Xifaxan | Rifaximin | 21 | suppressed |
| Glycopyrrolate | Glycopyrrolate | 20 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 20 | suppressed |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 19 | 13 |
| Humalog Kwikpen U-100 | Insulin Lispro | 19 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 19 | suppressed |
| Linzess | Linaclotide | 19 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 19 | suppressed |
| Amantadine | Amantadine Hcl | 18 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 18 | suppressed |
| Auryxia | Ferric Citrate | 18 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 18 | suppressed |
| Olanzapine | Olanzapine | 18 | suppressed |
| Rivastigmine | Rivastigmine | 18 | suppressed |
| Azithromycin | Azithromycin | 17 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 17 | suppressed |
| Fluconazole | Fluconazole | 17 | 15 |
| Latanoprost | Latanoprost | 17 | suppressed |
| Neupro | Rotigotine | 17 | suppressed |
| Lovastatin | Lovastatin | 16 | suppressed |
| Memantine Hcl | Memantine Hcl | 16 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 16 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 15 | suppressed |
| Colchicine | Colchicine | 15 | suppressed |
| Fentanyl | Fentanyl | 15 | suppressed |
| Lurasidone Hcl | Lurasidone Hcl | 15 | suppressed |
| Metolazone | Metolazone | 15 | suppressed |
| Nystatin | Nystatin | 15 | 11 |
| Paroxetine Hcl | Paroxetine Hcl | 15 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 15 | suppressed |
| Insulin Aspart Flexpen | Insulin Aspart | 14 | suppressed |
| Nateglinide | Nateglinide | 14 | suppressed |
| Amoxicillin | Amoxicillin | 13 | suppressed |
| Anastrozole | Anastrozole | 13 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 13 | suppressed |
| Carbamazepine Er | Carbamazepine | 13 | suppressed |
| Levofloxacin | Levofloxacin | 13 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 13 | suppressed |
| Methocarbamol | Methocarbamol | 13 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 13 | suppressed |
| Pyridostigmine Bromide | Pyridostigmine Bromide | 13 | suppressed |
| Tolterodine Tartrate | Tolterodine Tartrate | 13 | suppressed |
| Valsartan | Valsartan | 13 | suppressed |
| Victoza 2-Pak | Liraglutide | 13 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 12 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 12 | suppressed |
| Ketoconazole | Ketoconazole | 12 | suppressed |
| Lacosamide | Lacosamide | 12 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 12 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 12 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 12 | suppressed |
| Veltassa | Patiromer Calcium Sorbitex | 12 | suppressed |
| Hyoscyamine Sulfate | Hyoscyamine Sulfate | 11 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 11 | suppressed |
| Sodium Chloride | 0.9 % Sodium Chloride | 11 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 11 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $137.26 · 1 records | Boston Scientific Corporation | WATCHMAN FLX | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error